We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Pre-Op Weight Loss Improves Bariatric Surgery Outcomes

By HospiMedica International staff writers
Posted on 25 Apr 2018
Patients who lost at least 8% of their excess weight through a low-calorie diet (LCD) immediately before bariatric surgery have more successful long-term outcomes, according to a new study.

Researchers at the Greenville Health System (GHS; Greenville, SC, USA) conducted a study to determine the effect of preoperative excess weight loss (EWL) on postoperative outcomes in 355 patients undergoing primary vertical sleeve gastrectomy (SG) or Roux-en-Y gastric bypass (RYGB) between 2014 and 2016. More...
The LCD included 1,200 kcal/day (45% carbohydrates, 35% protein, 20% fat), which were consumed through five meal-replacement products and one food-based meal. All patients were also instructed to conduct 30 minutes of moderate to vigorous activity per day.

The LCD was observed for four weeks immediately preceding surgery. The patients were then divided into two cohorts and analyzed according to those who achieved an 8% or higher EWL (224 patients), and those who did not (131 patients). The primary endpoints included percent excess weight loss (% EWL) at 1, 3, 6, and 12 months postoperatively. The results revealed that patients who achieved an 8% or higher EWL were more successful at continued weight loss during the first year after surgery than the patients who did not lose as much weight preoperatively.

The cohort that achieved the target contained a greater proportion of men than did the other group (25.5% vs. 13.7%, respectively), a higher proportion of white patients (84.8% vs. 74.1%), and a higher proportion of patients taking antihypertensive medications (68.3% vs. 57.3%). The two groups had similar rates of preoperative comorbidities and surgery types. In addition, those who achieved the target weight loss had a shorter hospital stay and a higher % EWL at three months, six months, and one year post-operatively. The study was published in the April 2018 issue of the Journal of the American College of Surgeons (JACS).

“These findings suggest that surgeons and clinical care teams should encourage healthy eating and exercise. The program helped patients establish healthy eating habits, establish portion control and learn what a healthy meal looks like,” said lead author clinical nutrition specialist Deborah Hutcheon, DCN. “Weight loss from the liver and abdominal cavity helps to improve surgical access, which may be why surgical times and recovery periods went down.”

“We call it the honeymoon period of bariatric surgery. After a year or year and a half, your body starts to figure out what it can and can’t do, and your behaviors may change a little bit, so the odds that you are going to lose a significant amount of weight after that time period are definitely decreased,” said senior author John Scott, MD. “Therefore, the more weight you can lose during that honeymoon period, the better, because that effort will help establish a set point, in terms of where your steady weight is going to be further down the road.”

Related Links:
Greenville Health System


Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
Neonatal Heel Incision Device
Tenderfoot
Gold Member
Blood Gas Analyzer
i-Check200
Glucose Meter
StatStrip®
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image Credit: Adobe Stock

AI Platform Personalizes Support Between Visits for Cancer Survivors

Cancer survivors often manage persistent side effects after treatment, including fatigue, anxiety, uncertainty, symptoms, stress, and questions between appointments. Clinical teams need ways to maintain... Read more

Medical Imaging

view channel
Image: The tool analyzes 3D time-of-flight MR angiography to measure brain vessel length, radius, volume, branching, tortuosity, and other structural features. (Photo courtesy of University of Rochester Medical Center)

MRI Tool Analysis Identifies Vascular Differences in Cerebral Small Vessel Disease

Cerebral small vessel disease (CSVD) involves changes or damage to the brain’s small blood vessels and is associated with stroke and cognitive impairment. Magnetic resonance imaging (MRI) can show cerebral... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: The proposed acquisition would add NeoCast, an investigational next-generation liquid embolic technology for chronic subdural hematoma (cSDH), to Terumo Neuro’s neurovascular portfolio. (Photo courtesy of Arsenal Medical)

Terumo Neuro Acquisition Advances Liquid Embolic Technology for Chronic Subdural Hematoma

Terumo Neuro (Aliso Viejo, CA, USA) signed an agreement to acquire Arsenal Medical Inc. (Waltham, MA, USA), a privately held, clinical-stage biomaterials company. The proposed acquisition would add NeoCast,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.